4.7 Article

Clinical Outcome After Rectal Replacement With Side-to-End, Colon-J-Pouch, or Straight Colorectal Anastomosis Following Total Mesorectal Excision A Swiss Prospective, Randomized, Multicenter Trial (SAKK 40/04)

Journal

ANNALS OF SURGERY
Volume 269, Issue 5, Pages 827-835

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/SLA.0000000000003057

Keywords

colon J-pouch; colorectal reconstruction; evacuation score; incontinence score; Mesorectal excision; side-to-end anastomosis; straight colorectal anastomosis; straight colorectal anastomosis

Categories

Funding

  1. Oncosuisse [OCS 01579-08-2004]
  2. Swiss State Secretariat for Education, Research and Innovation (SERI)

Ask authors/readers for more resources

Objective: To compare, in a phase 3, prospective, randomized, multi-center clinical trial functional outcome of reconstruction procedures following total mesorectal excision (TME). Summary Background Data: Intestinal continuity reconstruction following TME is accompanied by postoperative defecation dysfunctions known as anterior resection syndrome. Commonly used reconstruction techniques are straight colorectal anastomosis (SCA), colon J -pouch (CJP), and side-toend anastomosis (SEA). Comparison of their functional outcomes in prospective, randomized, multi-center studies, including long-term assessments, is lacking. Methods: Patients requiring TME for histologically proven rectal tumor, with or without neoadjuvant treatment, age >= 18 years, normal sphincter function without history of incontinence, any pretreatment staging or adenoma, expected RO-resection, were randomized for standardized SCA, CJP, or SEA procedures. Primary endpoint was comparison of composite evacuation scores 12 months after TME. Comparison of composite evacuation and incontinence scores at 6, 18 and 24 months after surgery, morbidity, and overall survival represented secondary endpoints. Analysis was based on per protocol (PP) population, fully complying with trial requirements, and intention-to treat (ITT) population. Results: Three hundred thirty-six patients from 15 hospitals were randomized. PP population included 257 patients (JCP = 63; SEA = 95; SCA = 99). Composite evacuation scores of PP and ITC populations did not show statistically significant differences among the 3 groups at any time point. Similarly, composite incontinence scores for PP and ITT populations showed no statistically significant difference among the 3 trial arms at any time point. Conclusions: Within boundaries of investigated procedures, surgeons in charge may continue to perform reconstruction of intestinal continuity following TME at their technical preference.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland

Karin Ribi, Eleonora Pagan, Isabella Sala, Monica Ruggeri, Nadia Bianco, Eraldo Oreste Bucci, Rossella Graffeo, Markus Borner, Monica Giordano, Lorenzo Gianni, Manuela Rabaglio, Andrea Freschi, Elisabetta Cretella, Elena Seles, Alberto Farolfi, Edda Simoncini, Mariangela Ciccarese, Daniel Rauch, Adolfo Favaretto, Agnes Glaus, Rossana Berardi, Alessandra Franzetti-Pellanda, Vincenzo Bagnardi, Shari Gelber, Ann H. Partridge, Aron Goldhirsch, Olivia Pagani

Summary: This study investigated employment trajectories in young breast cancer survivors and found that most of them remained employed in the long-term. The study highlights the importance of regular evaluation of symptoms and financial discomfort in providing timely and individualized interventions and limiting reductions in work activities.

JOURNAL OF CANCER SURVIVORSHIP (2023)

Article Oncology

Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14]

Ursula Hasler-Strub, Andreas Mueller, Qiyu Li, Beat Thuerlimann, Karin Ribi, Stefan Gerber, Roger von Moos, Mathias Fehr, Christoph Rochlitz, Khalil Zaman, Stefan Aebi, Andreas Hochstrasser, Ute Gick, Daniela Baertschi, Stefan Greuter, Alexander Schreiber, Clemens B. Caspar, Andreas Trojan, Rosaria Condorelli, Thomas Ruhstaller

Summary: This study investigated the efficacy of reduced starting dose of first-line eribulin in patients aged >= 70 years with metastatic breast cancer. The results showed that the disease control rate was 40% with the reduced dose, and there was no cumulative neurotoxicity. Therefore, the study does not support the approach of a reduced starting dose in older patients.

JOURNAL OF GERIATRIC ONCOLOGY (2023)

Article Oncology

Impact of positive microscopic resection margins (R1) after gastrectomy in diffuse-type gastric cancer

Sergio Gaspar-Figueiredo, Pierre Allemann, Alexander B. J. Borgstein, Gaetan-Romain Joliat, Valentine Luzuy-Guarnero, Christophe Brunel, Christine Sempoux, Suzanne Sarah Gisbertz, Nicolas Demartines, Mark Ivo van Berge Henegouwen, Markus Schafer, Styliani Mantziari

Summary: This study aimed to assess the prognostic value of microscopically positive margins (R1) after gastrectomy on survival and tumor recurrence in diffuse-type gastric cancer (DTGC) patients. It showed that patients with R1 had poorer overall survival and disease-free survival, as well as higher early tumor recurrence rates. Therefore, achieving R0 resection should be pursued whenever possible.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Article Oncology

Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16)

Silke Gillessen, Giuseppe Procopio, Stefanie Hayoz, Eloise Kremer, Michael Schwitter, Orazio Caffo, David Lorente, Augusto Pedrazzini, Guilhem Roubaud, Soazig Nenan, Aurelius Omlin, Consuelo Buttigliero, Juan Ignacio Delgado Mingorance, Aranzazu Gonzalez-del-Alba, Maria Teresa Delgado, Franco Nole, Fabio Turco, Ricardo Pereira Mestre, Karin Ribi, Richard Cathomas

Summary: Darolutamide maintenance after successful taxane chemotherapy shows promising efficacy and safety in patients with metastatic castration-resistant prostate cancer (mCRPC).

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Medicine, General & Internal

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, Fedro A. Peccatori, Hatem A. Azim, Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna B. Saetersdal, Judith R. Kroep, Audrey Mailliez, Ellen Warner, Virginia F. Borges, Frederic Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset-Jablonski, Simona Borstnar, Junko Takei, Jeong E. Lee, Janice M. Walshe, Manuel Ruiz-Borrego, Halle C. F. Moore, Christobel Saunders, Vesna Bjelic-Radisic, Snezana Susnjar, Fatima Cardoso, Karen L. Smith, Teresa Ferreiro, Karin Ribi, Kathryn Ruddy, Roswitha Kammler, Sarra El-Abed, Giuseppe Viale, Martine Piccart, Larissa A. Korde, Aron Goldhirsch, Richard D. Gelber, Olivia Pagani

Summary: This study evaluated the risk of breast cancer recurrence among young breast cancer patients who temporarily discontinued hormone therapy to attempt pregnancy. The results showed that this interruption in therapy did not increase the risk of breast cancer events.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Oncology

Patient-reported experiences of cancer care related to the COVID-19 pandemic in Switzerland

Sara Colomer-Lahiguera, Claudia Canella, Stellio Giacomini, Kim Le Van, Carla Pedrazzani, Matthias Naegele, Laure Thouvenin, Alix O'Meara Stern, Rosaria Condorelli, Tourane Corbiere, Claudia M. Witt, Manuela Eicher, Karin Ribi

Summary: This study aims to describe the experience of Swiss oncological patients during the COVID-19 pandemic. The results show that Swiss cancer patients did not express major needs or disruptions in their care during this period and exhibited high levels of resilience.

SUPPORTIVE CARE IN CANCER (2023)

Review Medicine, General & Internal

Whole-Organ Pancreas and Islets Transplantations in UK: An Overview and Future Directions

David Martin, Piero Alberti, Nicolas Demartines, Melanie Phillips, John Casey, Andrew Sutherland

Summary: Whole-organ pancreas and islets transplantations are therapeutic options for type 1 diabetic patients with severe complications. The choice of treatment depends on factors such as kidney function, comorbidities, and treatment goals. Simultaneous pancreas and kidney transplant is often recommended for patients with end-stage kidney disease, but careful selection is necessary. New strategies, including dynamic organ perfusion technologies and stem cell therapies, aim to improve outcomes and reduce immune reactions. This article reviews the indications, surgical techniques, outcomes, and future directions of these transplantations.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Oncology

A Comprehensive Review of Prognostic Factors in Patients with Gastric Adenocarcinoma

Styliani Mantziari, Penelope St Amour, Francesco Abboretti, Hugo Teixeira-Farinha, Sergio Gaspar Figueiredo, Caroline Gronnier, Dimitrios Schizas, Nicolas Demartines, Markus Schafer

Summary: Despite recent therapeutical advances, gastric adenocarcinoma remains associated with a poor long-term survival. Diagnosis is often made at advanced stages, affecting prognosis. Factors such as tumor microenvironment, patient ethnicity, and therapeutic strategy play a role in patient outcome. This study aims to review existing knowledge on prognostic factors in gastric adenocarcinoma.

CANCERS (2023)

Article Surgery

Prospective compliance assessment of surgical site infection prevention measures in colorectal surgery

Philip Deslarzes, Jonas Jurt, Martin Hubner, Dieter Hahnloser, Daniel Clerc, Laurence Senn, Nicolas Demartines, Fabian Grass

BJS OPEN (2023)

Article Oncology

Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-PositiveMetastatic Breast Cancer A Secondary Analysis of a Randomized Clinical Trial

Jens Huober, Patrik Weder, Karin Ribi, Beat Thuerlimann, Jean-Christophe Thery, Qiyu Li, Laurence Vanlemmens, Severine Guiu, Etienne Brain, Julien Grenier, Florence Dalenc, Christelle Levy, Aude-Marie Savoye, Andreas Mueller, Veronique Membrez-Antonioli, Marie-Aline Gerard, Jerome Lemonnier, Hanne Hawle, Daniel Dietrich, Epie Boven, Herve Bonnefoi

Summary: In metastatic breast cancer, combining trastuzumab and pertuzumab with taxane-based chemotherapy is the standard of care. It is unclear if trastuzumab plus pertuzumab alone can be an optimal first-line strategy. This secondary analysis of a clinical trial suggests that the chemotherapy-free anti-ERBB2 strategy is feasible without compromising overall survival.

JAMA ONCOLOGY (2023)

Review Medicine, General & Internal

Pancreatic Cancer Surgery: What Matters to Patients?

David Martin, Piero Alberti, Stephen J. Wigmore, Nicolas Demartines, Gaetan-Romain Joliat

Summary: Pancreatic cancer is a deadly disease with unknown origins and limited treatment options. Surgical resection, the primary curative treatment, is associated with high morbidity and mortality rates and frequent recurrence. Patient-centered care and understanding patient perspectives are crucial for improving outcomes in pancreatic cancer surgery. Standardized patient-reported outcome and experience measures are needed to assess patient perspectives accurately.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Oncology

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14

D. Konig, S. Savic Prince, S. Hayoz, P. Zens, S. Berezowska, W. Jochum, E. Stauffer, V. Braunersreuther, B. Trachsel, S. Thierstein, M. Mark, S. Schmid, A. Curioni-Fontecedro, A. Addeo, I. Opitz, M. Guckenberger, M. Frueh, D. C. Betticher, H. -b. Ris, R. Stupp, S. I. Rothschild, L. Bubendorf, M. Pless

Summary: This study evaluated the impact of neoadjuvant treatment on PD-L1 expression in patients with stage III non-small-cell lung cancer. The results showed that neoadjuvant treatment did not influence PD-L1 expression, regardless of the specific treatment protocol. Additionally, the dynamic change of PD-L1 expression did not correlate with event-free survival or overall survival.

ESMO OPEN (2023)

Article Medicine, General & Internal

Educational Scoring System in Laparoscopic Cholecystectomy: Is It the Right Time to Standardize?

Elisa Reitano, Simone Famularo, Bernard Dallemagne, Kohei Mishima, Silvana Perretta, Pietro Riva, Pietro Addeo, Horacio J. Asbun, Claudius Conrad, Nicolas Demartines, David Fuks, Mariano Gimenez, Melissa E. Hogg, Charles Chung-Wei Lin, Jacques Marescaux, John B. Martinie, Riccardo Memeo, Olivier Soubrane, Michel Vix, Xiaoying Wang, Didier Mutter

Summary: This study aims to create a scoring system to calculate the learning curve of laparoscopic cholecystectomy (LC) based on the opinions of hepatobiliopancreatic (HPB) experts. Variables were selected through a questionnaire and ranked by experts. The scoring system can be used to assess the efficacy of LC within educational programs and surgical courses.

MEDICINA-LITHUANIA (2023)

Article Surgery

Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer

Walter P. Weber, Zoltan Matrai, Stefanie Hayoz, Christoph Tausch, Guido Henke, Frank Zimmermann, Giacomo Montagna, Florian Fitzal, Michael Gnant, Thomas Ruhstaller, Simone Muenst, Andreas Mueller, Loic Lelievre, Joerg Heil, Michael Knauer, Daniel Egle, Akos Savolt, Martin Heidinger, Christian Kurzeder

Summary: The association between axillary lymph node dissection (ALND) and systemic therapy in patients with clinically node-positive breast cancer was investigated. The study found that ALND did not inform systemic therapy recommendations.

JAMA SURGERY (2023)

Article Surgery

Machine learning to predict postoperative complications after digestive surgery: a scoping review

Maximilien Ravenel, Gaetan-Romain Joliat, Nicolas Demartines, Emilie Uldry, Emmanuel Melloul, Ismail Labgaa

BRITISH JOURNAL OF SURGERY (2023)

No Data Available